Displaying items by tag: oneal comprehensive cancer center

At UAB, undergraduate students with a passion for medicine have the option to receive a specialized degree in cancer biology — a degree found nowhere else in the country.
All of the newly diagnosed glioblastoma multiforme patients enrolled in a Phase 1 clinical trial have exceeded both their median and expected progression-free survivals. Two patients, to date, have exceeded their expected overall survival.
To facilitate gene-level queries of data from more than 10,000 cancer patient transcriptome sequences and proteomics data from 2,000 patients, researchers have developed a user-friendly cancer data analysis web platform called UALCAN.
The O’Neal Comprehensive Cancer Center is one of only 52 NCI-Designated Comprehensive Cancer Centers in the United States. This grant renewal award coincides with the 50th anniversary of the O’Neal Comprehensive Cancer Center, which received its first core grant and NCI designation in 1972.
Alyson Haynes beat breast cancer through her determination and a strong support system at the O’Neal Comprehensive Cancer Center at UAB.
The biodegradable nanovehicles accumulated in human breast cancer tumors in mice after systemic injection, and they inhibited oncogene expression and extended survival of the mice.
The drug inhibits the kinase Cdk5, found in mature neurons. Cdk5 has long been implicated in neuropsychiatric and neurodegenerative conditions, but previous inhibitors have largely failed to reach the brain through the blood-brain barrier.
Clinical trials serve as the bridge between research and patient care. Learn more about clinical trials, who can participate and why they play a vital role in cancer research.
UAB’s Isabel Scarinci will be honored as the first recipient of the TogetHER for Health’s Trailblazer of the Year Award.
For just the third time in history, a University of Alabama at Birmingham faculty member has been elected to the prestigious National Academy of Sciences.
According to the Alabama Department of Public Health, Alabama ranks fifth in the United States for oral cavity and pharynx cancer incidence and seventh among the states for oral cavity and pharynx cancer deaths.
Page 5 of 33